Our new line of professional and home treatments designed to respond to one of the most complex signs of skin aging to treat: melanoageing. It is the first system on the market specifically designed to address this emerging concept in dermatology, which links chronic hyperpigmentation to accelerated skin aging.

A new paradigm against dark spots

For years, hyperpigmentation treatment focused almost exclusively on skin bleaching. At Selvert MED, we propose a new approach based on the concept of melanoageing, understood as a multifactorial process including the progressive dysregulation of melanocytes, the accumulation of senescent cells in hyperpigmented lesions, oxidative stress from accumulated UV exposure, and inflammageing. This process not only manifests as spots and uneven tone, but also accelerates the structural and functional deterioration of the skin, requiring a global approach.

With this premise, MelanoBalance™ was developed under a multifunctional and personalized approach, based on the principle that hyperpigmentation has no single cause nor a single solution. The line acts simultaneously on the four phases of melanogenesis—activation, synthesis, transfer, and melanin accumulation—by combining cutting-edge active ingredients, advanced targeted delivery technologies, and formula synergies to achieve visible, safe results adapted to every skin type.

MelanoBalance™ is indicated for skin with hyperpigmentation of multifactorial origin, especially cases of melasma, post-inflammatory hyperpigmentation (PIH), ephelides, and lentigines.

Science and technology at the service of the skin

Our system is supported by five scientific pillars and a selection of high-performance active ingredients:

Transversal ingredients: Niacinamide and phytic acid, present throughout the line, with antioxidant, soothing, and pigment transfer-regulating action.
Reference depigmenting ingredients: Tranexamic acid, Azelaic acid, and Kojic dipalmitate, which contribute to reducing pigment formation.
Next-generation ingredients:
- BioTone-PDRN: Low molecular weight biotechnological polydeoxyribonucleotide, with antioxidant, renewing, and PIH-preventive action.
- NeoWhite-HR: Multimodal depigmenting agent that inhibits tyrosinase and blocks melanosome transfer.
- MelanoSense Bio-modulator: Biotechnological active of planktonic origin acting as a smart modulator of hypermelanogenesis.
- TGF-β mimic: Encapsulated biomimetic peptide regulating melanogenesis by acting on MITF (pigmentation regulation).
- MicroClear-S: Microneedle-inspired transdermal delivery system optimizing active ingredient penetration and accelerating visible results.